| Oct 28, 2025 |
Oct 30, 2025 |
Travere Therapeutics, Inc.
|
CEO |
Sell |
20.0
|
-120,000
|
-12.52%
|
✓
|
$3.6M |
| May 2, 2025 |
May 5, 2025 |
Travere Therapeutics, Inc.
|
CEO |
Sell |
35.0
|
-18,924
|
-4.32%
|
✓
|
$398.4K |
| Feb 11, 2025 |
Feb 12, 2025 |
Travere Therapeutics, Inc.
|
CEO |
Sell |
38.8
|
-11,375
|
-2.64%
|
✓
|
$273.5K |
| Jan 31, 2025 |
Feb 4, 2025 |
Travere Therapeutics, Inc.
|
CEO |
Sell |
100.0
|
+79,309
|
22.58%
|
✓
|
$1M |
| Jan 22, 2025 |
Jan 23, 2025 |
Travere Therapeutics, Inc.
|
CEO |
Sell |
41.3
|
-10,736
|
-2.97%
|
✓
|
$208.9K |
| Sep 5, 2024 |
Sep 9, 2024 |
Travere Therapeutics, Inc.
|
CEO |
Sell |
87.5
|
+11,375
|
3.24%
|
✓
|
$243.4K |
| Jan 31, 2024 |
Feb 2, 2024 |
Travere Therapeutics, Inc.
|
CEO |
Sell |
95.0
|
+115,878
|
49.37%
|
✓
|
$166.4K |
| Jan 23, 2024 |
Jan 25, 2024 |
Travere Therapeutics, Inc.
|
CEO |
Sell |
37.5
|
-7,873
|
-3.25%
|
✓
|
$70.5K |
| Aug 31, 2023 |
Sep 5, 2023 |
Travere Therapeutics, Inc.
|
CEO |
Sell |
82.5
|
+5,445
|
2.30%
|
✓
|
$65.5K |
| Jan 31, 2023 |
Feb 2, 2023 |
Travere Therapeutics, Inc.
|
CEO |
Sell |
95.0
|
+89,304
|
60.40%
|
✓
|
$182.4K |
| Jan 24, 2023 |
Jan 26, 2023 |
Travere Therapeutics, Inc.
|
CEO |
Sell |
37.5
|
-6,442
|
-4.18%
|
✓
|
$138.5K |
| Jan 5, 2023 |
Jan 6, 2023 |
Travere Therapeutics, Inc.
|
CEO |
Sell |
37.5
|
-5,625
|
-3.52%
|
✓
|
$116.7K |
| Feb 10, 2022 |
Feb 11, 2022 |
Travere Therapeutics, Inc.
|
CEO |
Sell |
41.3
|
-4,832
|
-2.93%
|
✓
|
$134.5K |
| Jan 31, 2022 |
Feb 2, 2022 |
Travere Therapeutics, Inc.
|
CEO |
Sell |
95.0
|
+33,035
|
25.08%
|
✓
|
$131.9K |
| Jan 24, 2022 |
Jan 26, 2022 |
Travere Therapeutics, Inc.
|
CEO |
Sell |
32.5
|
-7,873
|
-5.64%
|
✓
|
$196.7K |
| Jan 4, 2022 |
Jan 6, 2022 |
Travere Therapeutics, Inc.
|
CEO |
Sell |
22.5
|
-17,332
|
-11.05%
|
✓
|
$521.4K |
| Aug 13, 2021 |
Aug 17, 2021 |
Travere Therapeutics, Inc.
|
CEO |
Sell |
90.0
|
+9,664
|
6.56%
|
✗
|
$134.1K |
| Jun 1, 2021 |
Jun 3, 2021 |
Travere Therapeutics, Inc.
|
CEO |
Sell |
32.5
|
-9,562
|
-6.10%
|
✓
|
$139.8K |
| Feb 5, 2021 |
Feb 9, 2021 |
Travere Therapeutics, Inc.
|
CEO |
Sell |
30.0
|
-9,626
|
-5.78%
|
✓
|
$303.2K |
| Feb 3, 2021 |
Feb 3, 2021 |
Travere Therapeutics, Inc.
|
CEO |
Sell |
45.0
|
-2,406
|
-1.59%
|
✓
|
$69.6K |
| Jan 31, 2021 |
Feb 2, 2021 |
Travere Therapeutics, Inc.
|
CEO |
Sell |
90.0
|
+6,266
|
4.32%
|
✓
|
$261.3K |
| Jan 5, 2021 |
Jan 7, 2021 |
Travere Therapeutics, Inc.
|
CEO |
Sell |
32.5
|
-6,876
|
-7.26%
|
✓
|
$184.5K |
| Sep 18, 2020 |
Sep 22, 2020 |
Travere Therapeutics, Inc.
|
CEO |
Sell |
95.0
|
+17,195
|
22.19%
|
✗
|
$208.3K |
| Jan 7, 2020 |
Jan 8, 2020 |
Travere Therapeutics, Inc.
|
CEO |
Sell |
25.0
|
-7,500
|
-15.00%
|
✓
|
$109.1K |